Scientists Prime The Immune System As A Powerful Cancer Weapon
Review of ASCO starting with the summary of a proof-of principle study presented by NCI answering the question if T-cells could be utilized to fight solid tumors.
Our immune systems can unmask tumours and cure cancer, experts say, calling immuno-oncology the biggest breakthrough in years
Review of cancer immunotherapy study results from several drug companies recently presented at ASCO conference including comments to the status of Immunotherapy by several oncology experts from pharmaceutical industry and academic research such as David Hafler (Yale University), Dr. Roy Baynes (senior vice-preseident of clinical research at Merck) and Michael Giordano (Head of Oncology at BMS).
Pharma vies to unleash immune system power on cancer
An overview of ongoing cancer immunotherapy trials and related achievements of the major drug companies chasing to get a share of the estimated enormous market potential of immuno-oncology drugs.